99 results on '"Tamburino, Corrado"'
Search Results
2. Impact of balloon post‐dilation on valve durability and long‐term clinical outcomes after self‐expanding transcatheter aortic valve implantation
3. Mid‐term outcomes and hemodynamic performance of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: Insights from the bicuSpid TAvi duraBILITY (STABILITY) registry
4. Postprocedural trans‐mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge‐to‐edge repair
5. Edge‐to‐edge percutaneous mitral repair for functional ischaemic and non‐ischaemic mitral regurgitation: a systematic review and meta‐analysis
6. Clinical outcomes and predictors in patients with previous cardiac surgery undergoing mitral valve transcatheter edge‐to‐edge repair
7. Real‐world experience with the new Watchman FLX device: Data from two high‐volume Sicilian centers. The FLX‐iEST registry
8. Parenteral Anticoagulant Agents in PCI
9. Risk Stratification Approach to Multivessel Coronary Artery Disease
10. Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement
11. Predictors of optimal procedural result after transcatheter edge‐to‐edge mitral valve repair in secondary mitral regurgitation
12. Italian Society of Interventional Cardiology ( GIse ) registry Of Transcatheter treatment of mitral valve r egurgitaTiOn ( GIOTTO ): impact of valve disease aetiology and residual mitral regurgitation after MitraClip implantation
13. Introduction
14. Annular Rupture
15. Effect of post‐procedural evidence‐based therapy on 2‐year prognosis after transcatheter mitral valve repair
16. Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project
17. When antegrade microcatheter does not follow: The “facilitated tip‐in technique”
18. Prospective evaluation of drug eluting self‐apposing stent for the treatment of unprotected left main coronary artery disease: 1‐year results of the TRUNC study
19. Outcomes of three different new generation transcatheter aortic valve prostheses
20. Coronary lithotripsy for failed rotational atherectomy, cutting balloon, scoring balloon, and ultra‐high‐pressure non‐compliant balloon
21. Self‐expandable sirolimus‐eluting stents compared to second‐generation drug‐eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS‐2 registries
22. Clinical impact of optical coherence tomography findings on culprit plaque in acute coronary syndrome: The OCT‐FORMIDABLE study registry
23. Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization
24. Restenosis patterns after bioresorbable vascular scaffold implantation: Angiographic substudy of the GHOST-EU registry
25. Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EURegistry
26. Culprit plaque characteristics in younger versus older patients with acute coronary syndromes: An optical coherence tomography study from the FORMIDABLE registry
27. Unusual interatrial membrane in the left atrium: A newer obstacle for transseptal-based percutaneous mitral valve repair techniques?
28. A propensity score matched comparative study between paclitaxel‐coated balloon and everolimus‐eluting stents for the treatment of small coronary vessels
29. Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE‐CARDIOGROUP IV and USZ registry
30. Update on clinical evidence (Part II): A summary of the main post market studies
31. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry
32. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry
33. Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry
34. EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology
35. Reference Values for Real Time Three-Dimensional Echocardiography-Derived Left Ventricular Volumes and Ejection Fraction: Review and Meta-Analysis of Currently Available Studies
36. Multicenter evaluation of transcatheter aortic valve replacement using either SAPIEN XT or CoreValve: Degree of device oversizing by computed-tomography and clinical outcomes
37. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta‐analysis of 5,971 patients
38. Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry
39. Effectiveness of MitraClip Therapy in Patients with Refractory Heart Failure
40. Gender-related clinical and echocardiographic outcomes at 30-day and 12-month follow up after MitraClip implantation in the GRASP registry
41. New insights on acute expansion and longitudinal elongation of bioresorbable vascular scaffolds in vivo and at bench test: A note of caution on reliance to compliance charts and nominal length
42. Impact on Prognosis of Periprocedural Bleeding after TAVI: Mid-Term Follow-Up of a Multicenter Prospective Study
43. The SYNTAX score does not predict presence of carotid disease in a multivessel coronary disease population
44. Subclavian transectional stent fracture and migration to the aortic carrefour: A case description of retrieval by snare system
45. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: Implications of varying definitions of contrast-induced nephropathy
46. Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery
47. Early cardiovascular remodelling in Fabry disease
48. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention
49. Late MitraClip procedure after left atrial appendage occlusion
50. Paclitaxel‐ and sirolimus‐eluting stents in older patients with diabetes mellitus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.